Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2022

Jul 22, 2022

32939_dirs_2022-07-22_6f26ff5c-af1a-4dfc-bd03-2b94707bc683.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2022-07-20

Reporting Person: Licitra Karen A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-07-20 Common Stock A 7060 Acquired 35178 Direct

Footnotes

F1: The acquisition of 7,060 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 7,060 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/20/2023.